Danielle Boyle: Honoured to Chair ITP Symposium at the EHA 2026
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, shared on LinkedIn:
”I’m incredibly honoured to be chairing an upcoming symposium at the EHA 2026 Congress next month.
To not only be invited to contribute but also to chair a panel of such highly esteemed clinicians, alongside a fellow patient advocate, is something I’m genuinely proud of.
These are individuals who are shaping the future of ITP care, and it is a privilege to help guide an important and meaningful discussion while continuing to keep patients at the centre of everything we strive to achieve.
What makes this opportunity even more significant is what it represents.
Seeing patient organisations included at this level is a strong step in the right direction and a clear reflection of the shift towards putting patients at the centre of care, research, and decision-making.
This is exactly where we need to be.
Collaborative, inclusive, and grounded in lived experience alongside clinical expertise.
If you are attending EHA 2026 this year, I would love for you to join us.
You can find the session details.
I am looking forward to being part of the conversation and continuing to advocate for a more patient-centred future in ITP.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series